If you notice red, itchy welts suddenly popping up on your skin, you may start to panic. Are you having an allergic reaction? Did you catch something contagious? But your mystery rash may have a much ...
If you’ve developed a rash that’s hot, swollen, bumpy, or itchy, it’s possible you have hives. Finding hives on your skin can be unsettling, and usually you can’t be sure where they came from. No ...
September 29, 2006 —The US Food and Drug Administration (FDA) has approved first-time generic formulations for caffeine citrate 10-mg/mL intravenous injection and 10-mg/mL oral solution for the ...
In September 2025, the US Food and Drug Administration (FDA) approved Rhapsido ® (remibrutinib), an oral small molecule kinase inhibitor, for the treatment of chronic spontaneous urticaria (CSU) in ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
A panel of experts discuss the clinical trials of dupilumab, the resultant data, and the response of the FDA when approval was requested. Dupilumab has been evaluated in phase 3 clinical trials in ...
Xolair (omalizumab) is a prescription drug used to treat chronic (ongoing) hives without a known cause. Xolair is a biologic drug and does not come in a biosimilar version. It’s used when symptoms ...
Mpox is an infectious viral condition, whereas hives are a symptom of high histamine production or allergic reaction. Both conditions can cause bumps on your skin, but they differ in size, duration, ...
The reality of living with chronic hives -- which by definition last for 6 weeks or longer and have no apparent specific trigger -- can be very challenging. About half of people with "chronic ...
If you've ever had an allergic reaction that includes hives-a rash with itchy, raised bumps or welts-then you know how uncomfortable they are. In addition to the intense, sometimes uncontrollable ...
Please provide your email address to receive an email when new articles are posted on . Urticaria patients taking Dupixent experienced an 8.64-point reduction in itch and 15.86-point reduction in ...
UpToDate: "Chronic spontaneous urticaria: treatment of refractory symptoms." American Academy of Allergy, Asthma, and Immunology: "Hives (Urticaria) and Angioedema Overview." DermNet New Zealand Trust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results